Budget impact of oral semaglutide intensification versus sitagliptin among US patients with type 2 diabetes uncontrolled with metformin

The above plain language summary and video abstract represent the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

© The authors, CC-BY-NC 2020.